+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

Medicaments, Containing Hormones - International Trade in Q4-2024: Top Markets' Performance by Major Competitors - Product Thumbnail Image

Medicaments, Containing Hormones - International Trade in Q4-2024: Top Markets' Performance by Major Competitors

  • Report
  • January 2025
  • 600 Pages
  • Global
From
Non-injectable Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Non-injectable Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2025
  • 187 Pages
  • Global
From
Medicaments Containing Hormones in the Form of Doses: World Trade, Markets and Competitors - Product Thumbnail Image

Medicaments Containing Hormones in the Form of Doses: World Trade, Markets and Competitors

  • Report
  • November 2024
  • 750 Pages
  • Global
From
Medicaments Containing Insulin Doses in the Form: World Trade, Markets and Competitors - Product Thumbnail Image

Medicaments Containing Insulin Doses in the Form: World Trade, Markets and Competitors

  • Report
  • November 2024
  • 750 Pages
  • Global
From
Medicaments, Containing Hormones: World Trade, Markets and Competitors - Product Thumbnail Image

Medicaments, Containing Hormones: World Trade, Markets and Competitors

  • Report
  • November 2024
  • 750 Pages
  • Global
From
Medicaments Containing Insulin: World Trade, Markets and Competitors - Product Thumbnail Image

Medicaments Containing Insulin: World Trade, Markets and Competitors

  • Report
  • November 2024
  • 750 Pages
  • Global
From
Human Insulin Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product Type, Application, and End-user - Product Thumbnail Image

Human Insulin Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product Type, Application, and End-user

  • Report
  • September 2024
  • 117 Pages
  • Global
From
Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033 - Product Thumbnail Image

Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033

  • Report
  • June 2024
  • 67 Pages
  • Europe
From
Europe Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report by Treatment (Biologics, Wound Care Dressings), Type (Neuro-Ischemic, Neuropathic), End-use, Country, and Segment Forecasts, 2025-2030 - Product Thumbnail Image

Europe Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report by Treatment (Biologics, Wound Care Dressings), Type (Neuro-Ischemic, Neuropathic), End-use, Country, and Segment Forecasts, 2025-2030

  • Report
  • October 2024
  • 124 Pages
  • Europe
From
Asia-Pacific Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033 - Product Thumbnail Image

Asia-Pacific Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033

  • Report
  • July 2024
  • 59 Pages
  • Asia Pacific
From
United States Insulin Pens Market Size, Insights, Competitive Landscape, and Forecast, 2025 - 2033 - Product Thumbnail Image

United States Insulin Pens Market Size, Insights, Competitive Landscape, and Forecast, 2025 - 2033

  • Report
  • June 2025
  • 90 Pages
  • United States
From
United States Diabetes Market Report: 2024-2032 - Product Thumbnail Image

United States Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 139 Pages
  • United States
From
United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • United States
From
Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • May 2025
  • 200 Pages
  • Europe
From
Europe Synthetic Hormones Market, By Country, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Europe Synthetic Hormones Market, By Country, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • January 2025
  • 133 Pages
  • Europe
From
United States Fabry Disease Treatment Market, By Region, Competition, Forecast and Opportunities, 2019-2029F - Product Thumbnail Image

United States Fabry Disease Treatment Market, By Region, Competition, Forecast and Opportunities, 2019-2029F

  • Report
  • August 2024
  • 85 Pages
  • United States
From
North America Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031 - Product Thumbnail Image

North America Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031

  • Report
  • August 2024
  • 110 Pages
  • North America
From
LAMEA Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031 - Product Thumbnail Image

LAMEA Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031

  • Report
  • August 2024
  • 121 Pages
  • Africa, Middle East
From
Europe Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031 - Product Thumbnail Image

Europe Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031

  • Report
  • August 2024
  • 121 Pages
  • Europe
From
Asia-Pacific Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031 - Product Thumbnail Image

Asia-Pacific Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031

  • Report
  • August 2024
  • 121 Pages
  • Asia Pacific
From
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more